Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 5.84% is 88% above its 5-year average of 3.10%, near the high end of its 5-year range (1.00%–7.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.95% below its 12-month average of 5.90%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.84%.
DEBT TO ASSETS RATIO
5.84%
DEBT TO ASSETS RATIO AVG TTM
5.90%
DEBT TO ASSETS RATIO AVG 3Y
4.20%
DEBT TO ASSETS RATIO AVG 5Y
3.10%
DEBT TO ASSETS RATIO AVG 10Y
2.12%
DEBT TO ASSETS RATIO AVG 15Y
0.65%
DEBT TO ASSETS RATIO AVG 20Y
0.40%
CURRENT VS TTM AVG
-0.95%
CURRENT VS 3Y AVG
+38.95%
CURRENT VS 5Y AVG
+88.28%
CURRENT VS 10Y AVG
+175.71%
CURRENT VS 15Y AVG
+791.94%
CURRENT VS 20Y AVG
+1370.00%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+6389.09%
vs the sector median at left
Oncolytics Biotech Inc.
Market Cap
$60.02M
Debt to Assets Ratio
5.84%
TTM Avg
5.90%
3Y Avg
4.20%
5Y Avg
3.10%
Market Cap
$60.24M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.42M
Debt to Assets Ratio
0.74%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$59.18M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.44M
Debt to Assets Ratio
0.50%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.29M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$57.76M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oncolytics Biotech Inc. (ONCY) | $60.02M | 5.84% | 5.90% | 4.20% | 3.10% |
| Kalaris Therapeutics Inc (KLRS)vs › | $60.24M | 0.01% | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | 0.74% | N/A | N/A | N/A |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | 0.04% | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | 0.50% | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | 0.09% | N/A | N/A | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | 0.00% | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | 0.00% | N/A | N/A | N/A |
| Talphera, Inc. (TLPH)vs › | $57.61M | 0.00% | N/A | N/A | N/A |
| RenovoRx, Inc. (RNXT)vs › | $62.62M | 0.02% | N/A | N/A | N/A |
Debt/Assets
5.8%
Debt/Equity
N/A
Current Ratio
1.35
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 5.84% |
| 2026-03-31 | 6.22% |
| 2025-12-31 | 7.43% |
| 2025-09-30 | 5.55% |
| 2025-06-30 | 4.45% |
| 2025-03-31 | 5.08% |
| 2024-12-31 | 5.27% |
| 2024-09-30 | 4.39% |
| 2024-06-30 | 3.48% |
| 2024-03-31 | 3.24% |
| 2023-12-31 | 1.09% |
| 2023-09-30 | 1.12% |
| 2023-06-30 | 1.50% |
| 2023-03-31 | 1.60% |
| 2022-12-31 | 1.00% |
| 2022-09-30 | 1.18% |
| 2022-06-30 | 1.30% |
| 2022-03-31 | 1.31% |
| 2021-12-31 | 1.43% |
| 2021-09-30 | 1.35% |
| 2021-06-30 | 1.32% |
| 2021-03-31 | 1.15% |
| 2020-12-31 | 1.17% |
| 2020-09-30 | 1.65% |
| 2020-06-30 | 0.94% |
| 2020-03-31 | 1.27% |
| 2019-12-31 | 2.58% |
| 2019-09-30 | 3.71% |
| 2019-06-30 | 4.51% |
| 2019-03-31 | 4.73% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.45% |
| 2006-09-30 | 0.39% |
| 2006-06-30 | 0.37% |
| 2006-03-31 | 0.34% |
| 2005-12-31 | 0.32% |
| 2005-09-30 | 0.43% |
| 2005-06-30 | 0.39% |
| 2005-03-31 | 0.37% |
| 2004-12-31 | 0.38% |
| 2004-09-30 | 0.51% |
| 2004-06-30 | 0.48% |
| 2004-03-31 | 0.59% |
| 2003-12-31 | 0.58% |
| 2003-09-30 | 0.70% |
| 2003-06-30 | 0.80% |
| 2003-03-31 | 0.90% |
| 2002-12-31 | 0.83% |
| 2002-09-30 | 0.93% |
